SG Biofuels Closes Series A financing Round With $9.4 Million

SG Biofuels Inc. closed a Series A financing round with $9.4 million. Flint Hills Resources LLC and Life Technologies Corp. participated in the funding of the Encinitas, Calif.-based bioenergy crop company.


SG Biofuels, Inc., a bioenergy crop company developing and producing elite seeds of Jatropha, today announced it has completed a $9.4 million Series A financing with proceeds from Flint Hills Resources, a privately held company based in Kansas, Life Technologies Corporation, a biotechnology tools company based in Carlsbad, Calif., and participation from existing investors. The financing will support the company’s efforts to advance Jatropha as a high-yielding, low cost feedstock for diesel, jet fuel and petrochemicals.

SG Biofuels also announced that Anthony Sementelli, chief financial officer of Flint Hills Resources, and Nathan Wood, vice president of Life Technologies’ Genomics Technologies business segment, have joined the company’s board of directors.

“We are very pleased to complete this financing with high-caliber partners that bring strategic value to our business model, and to have the round oversubscribed further validates our approach,” said Kirk Haney, president and chief executive officer at SG Biofuels. “Our integrated platform of breeding, biotechnology and agronomy provides a significant opportunity for SG Biofuels and our partners to create a thriving global market for crude Jatropha oil.”

Jatropha curcas is a non-edible shrub that is native to Central America. Its seeds contain high amounts of oil that can be used for a variety of bio-based materials and feedstock substitutes. It can be effectively grown on marginal lands that are considered undesirable for food crops.

Earlier this year, SG Biofuels and Life Technologies formed a strategic alliance to further accelerate the development of Jatropha through use of Life Technologies’ biotechnology and synthetic biology tools. The companies recently announced they have completed the sequence of the Jatropha genome.

SG Biofuels has assembled the world’s largest and most diverse library of Jatropha genetic material and developed a crop improvement platform that has doubled the yield of Jatropha, while reducing input costs for growers.

The company’s integrated breeding and biotechnology approach forms the foundation for its JMax Jatropha Optimization Platform, providing research agencies, growers and plantation developers with access to the company’s germplasm library, the genome sequence, molecular markers and advanced biotech and synthetic biology tools to optimize elite Jatropha cultivars for unique growing conditions around the world. The company has also introduced JMax 100, an elite Jatropha cultivar optimized for growing conditions in Guatemala, with projected yields 100 percent greater than existing commercial varieties, resulting in a 300 percent increase in profits for growers.

About SG Biofuels

SG Biofuels is a bioenergy crop company using breeding and biotechnology to develop and produce elite seeds of Jatropha. With the largest and most diverse library of Jatropha genetic material, SG Biofuels is turning the opportunities of Jatropha into reality through a world-class leadership team, leading-edge science and genetics and expertise in agronomy and plantation management. SG Biofuels has been named one of the Top 50 Companies in Bioenergy by Biofuels Digest and one of the Top 100 Emerging Cleantech Companies by Always On.

About Flint Hills Resources

Flint Hills Resources, LLC is a refining and petrochemical company based in Wichita, Kansas. As an independently managed, wholly-owned subsidiary of Koch Industries, Inc., it has completed acquisitions and capital expenditures of more than $5 billion since 2002.

About Life Technologies

Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: Follow Life Technologies on Twitter @LIFECorporation and on Facebook.